Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies-Reference-Cited by-同舟云学术

Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies

Published:2013-06 Issue:23 Volume:61 Page:2355-2362
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Bosch Xavier,Rovira Montserrat,Sitges Marta,Domènech Ariadna,Ortiz-Pérez José T.,de Caralt Teresa M.,Morales-Ruiz Manuel,Perea Rosario J.,Monzó Mariano,Esteve Jordi

Funder

Instituto de Salud Carlos III

FEDER, European Union

Una manera de hacer Europa

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. Cancer survivorship: genetic susceptibility and second primary cancers: research strategies and recommendations;Travis;J Natl Cancer Inst,2006

2. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management;Yeh;Circulation,2004

3. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation

4. Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin’s lymphoma patients undergoing autologous stem cell transplantation;Kuittinen;Eur J Haematol,2006

5. Subacute cardiac toxicity following autologous haematopoietic stem cell transplantation in patients with normal cardiac function;Chung;Heart,2008

Cited by 522 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotection strategies for anthracycline cardiotoxicity;Basic Research in Cardiology;2024-09-09

2. Use of EMPAgliflozin in the prevention of CARDiotoxicity: the EMPACARD – PILOT trial;Cardio-Oncology;2024-09-05

3. Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity;European Journal of Heart Failure;2024-08-30

4. Cancer and Heart Failure: Dangerous Liaisons;Journal of Cardiovascular Development and Disease;2024-08-27

5. Cardiovascular Disease After Hematopoietic Stem Cell Transplantation in Adults;JACC: CardioOncology;2024-08